PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

An RP-HPLC method for simultaneous analysis of, and interaction studies on, enalapril maleate and H 2 -receptor antagonists

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A simple, sensitive, and rapid RP-HPLC method for analysis of enalapril in the presence of H 2 -receptor antagonists has been developed and validated. Enalapril maleate was separated from H 2 -receptor antagonists by use of a 250 mm × 4.6 mm, 5-µm particle, C 18 column with 86:14 ( υ / υ ) methanol-water, pH adjusted to 3.5, as mobile phase, at a flow rate of 1.5 mL min -1. UV detection was performed at 227 nm. The retention times of enalapril maleate, ranitidine, cimetidine, and famotidine were 3, 5, 7, and 7.5 min, respectively. The detection limit for enalapril was 10 ng mL -1 and the calibration plot was linear in the range 2.5–50 µg mL -1. In-vitro interaction of enalapril with the commonly administered H 2 -receptor antagonists cimetidine, ranitidine, and famotidine in simulated gastric juice at different pH and 37°C was also studied by use of this method. These studies clearly indicated that most of these H 2 -receptor antagonists bind to enalapril causing drastic changes in the availability of the drug. The HPLC method is accurate, selective, sensitive, and reproducible.
Rocznik
Strony
547--558
Opis fizyczny
Bibliogr. 23 poz., rys., tab.
Twórcy
autor
  • University of Karachi Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy Karachi 75270 Pakistan
autor
  • University of Karachi Department of Chemistry Karachi 75270 Pakistan
autor
  • University of Karachi Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy Karachi 75270 Pakistan
autor
  • University of Karachi Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy Karachi 75270 Pakistan
Bibliografia
  • [1] G.G. Alfred, S.G. Louis, W.R. Theodore, and M. Ferid, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill, 904 (1996)
  • [2] R.G. Pendleton, P.G. Cook, A. Shepherd-Rose, and A.W. Mangel, Pharmacol. Exp. Ther. 1 , 64–69 (1985)
  • [3] H. Tajerzadeh and M. Hamidi, J. Pharm. Biomed. Anal., 4 , 675–680 (2001)
  • [4] K.H. Yoon, W. Kim, J. Park, and H.J. Kim, Bull. Korean Chem. Soc., 6 , 878–880 (2004)
  • [5] V.V. Pisarev, N.E. Moskaleva, Y.B. Zverkov, L.B. Smirnova, V.G. Belolipetskaya, and Y.V. Sukhanov, Pharm. Chem. J. 2 , 104–107 (2005)
  • [6] W.C. Randolph, V.L. Osborne, S.S. Walkenstein, A.P. Intoccia, J. Pharm. Sci., 66 , 1148–1150 (1977)
  • [7] G.M. Kochak, A. Rakhit, T.N. Thompson, and M.E. Hurley, J. Clin. Pharmacol., 28 , 222–227 (1988)
  • [8] N. Sultana, M.S. Arayne, and R. Quresh, Pak. J. Pharm. Sci., 20 , 132–139 (2007)
  • [9] T. Rosenthal, D. Ezra, Drug Saf., 13 , 157–187 (1995)
  • [10] H. Shionoiri, Clin. Pharmacokinet., 25 , 20–58 (1993)
  • [11] ICH harmonised tripartite guideline, Q3A(R2) (2006)
  • [12] http://www.drugs.com/mtm/diltiazem-and-enalapril.html
  • [13] A. Mushtaq, Essent. Med. Biochem. 4 , 176 (1982)
  • [14] J.P. Mordes and W.E.C. Wasker, Pharmacol. Rev., 29 , 273 (1978)
  • [15] R.K. Rude and F.R. Singer, Annu. Rev. Med., 32 , 245 (1981)
  • [16] M.M. Pechet, E. Bobadilla, E.L. Carroll, and R.H. Hess, Am. J. Med., 43 , 696 (1967)
  • [17] A. Beddall, Practitioner, 234 , 714 (1990)
  • [18] E. Mayer and T.M. Adieles, World Health Stat. Q., 38 , 302 (1985)
  • [19] R.G. Alfanso, Remington’s Pharmaceutical Science, 19th edn, Mack Publishing, Easton, Pennsylvania, pp 940–970 (1995)
  • [20] J.R. Duffield, S.B. Hall, D.R. William, and M.I. Barnett, Safer Total Parenteral Nutrition Based on Speciation Analysis. In: G.P. Ellis and G.B. West (Eds) Progress in Medical Chemistry, Vol. 28, Elsevier, Amsterdam, 1991
  • [21] P.R. Dallman, Semin. Hematol., 19 , 19 (1982)
  • [22] N. Sultana, S. Arayne, A. Sana, Pak. J. Pharm. Sci., 20 , 19–25 (2007)
  • [23] M. Cassimjee, Pharmaceutical Services, The kzn pharmacy and therapeutics bulletin, 10 (2006)
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-24a54ead-596c-4972-95f7-18c79e7afac9
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.